1. Home
  2. HOTH vs TSE Comparison

HOTH vs TSE Comparison

Compare HOTH & TSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hoth Therapeutics Inc.

HOTH

Hoth Therapeutics Inc.

HOLD

Current Price

$0.95

Market Cap

16.6M

Sector

Health Care

ML Signal

HOLD

Logo Trinseo PLC

TSE

Trinseo PLC

HOLD

Current Price

$0.46

Market Cap

19.9M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
HOTH
TSE
Founded
2017
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
16.6M
19.9M
IPO Year
2019
2014

Fundamental Metrics

Financial Performance
Metric
HOTH
TSE
Price
$0.95
$0.46
Analyst Decision
Strong Buy
Hold
Analyst Count
2
1
Target Price
$4.50
$1.00
AVG Volume (30 Days)
649.7K
1.2M
Earning Date
11-12-2025
02-13-2026
Dividend Yield
N/A
4.00%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$3,133,800,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$4.11
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.66
$0.43
52 Week High
$2.12
$5.99

Technical Indicators

Market Signals
Indicator
HOTH
TSE
Relative Strength Index (RSI) 34.10 38.28
Support Level $1.00 $0.43
Resistance Level $1.13 $0.95
Average True Range (ATR) 0.07 0.08
MACD -0.00 -0.00
Stochastic Oscillator 3.67 5.02

Price Performance

Historical Comparison
HOTH
TSE

About HOTH Hoth Therapeutics Inc.

Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA).

About TSE Trinseo PLC

Trinseo PLC is a materials company and manufacturer of latex and plastics products. The company's operating segments include Latex Binders, Americas Styrenics, Engineered Materials, and Polymer Solutions. Maximum revenue is generated from its Polymer Solutions segment, which consists of various polymers, the majority of which are for automotive, building, and construction applications. The product offerings of this segment include ABS, styrene-acrylonitrile, polystyrene, and polycarbonate products, which are marketed through brands like Magnum and Styron. Geographically, the company generates maximum revenue from Europe, followed by the United States, Asia-Pacific, and the Rest of the world.

Share on Social Networks: